ASSET PURCHASE AGREEMENT by and between Atreca, Inc. and Immunome, Inc. Dated as of December 22, 2023Asset Purchase Agreement • December 26th, 2023 • Atreca, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 26th, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and executed as of December 22, 2023 (the “Execution Date”), by and between Atreca, Inc., a Delaware corporation (“Seller”) and Immunome, Inc., a Delaware corporation (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ASSET PURCHASE AGREEMENT by and between Atreca, Inc. and Immunome, Inc. Dated as of December 22, 2023Asset Purchase Agreement • December 26th, 2023 • Atreca, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 26th, 2023 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and executed as of December 22, 2023 (the “Execution Date”), by and between Atreca, Inc., a Delaware corporation (“Seller”) and Immunome, Inc., a Delaware corporation (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”